Guidance A-Z — P
246 guidance documents beginning with P.
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal)
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer
Padeliporfin for untreated localised prostate cancer
Paige Prostate for prostate cancer
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Palliative care for adults: strong opioids for pain relief
Palliative photodynamic therapy for advanced oesophageal cancer
Pancreatic cancer
Pancreatic cancer in adults: diagnosis and management
Pancreatitis
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)
Panobinostat for treating multiple myeloma after at least 2 previous treatments
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers
Parkinson's disease
Parkinson's disease in adults
Partial replacement of the meniscus of the knee using a biodegradable scaffold
Path Finder for freezing of gait in people with Parkinson's disease
Patient experience in adult NHS services
Patient experience in adult NHS services: improving the experience of care for people using adult NHS services
Patient group directions
Patient Status Engine for wireless monitoring of vital signs
Patiromer for treating hyperkalaemia
Patisiran for treating hereditary transthyretin amyloidosis
Pazopanib for the first-line treatment of advanced renal cell carcinoma
pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms
Pegaspargase for treating acute lymphoblastic leukaemia
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis
Pegunigalsidase alfa for treating Fabry disease
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (terminated appraisal)
Pegzilarginase for treating arginase-1 deficiency in people 2 years and over
Pelvic floor dysfunction: prevention and non-surgical management
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
Pembrolizumab for adjuvant treatment of renal cell carcinoma
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma
Pembrolizumab for advanced melanoma not previously treated with ipilimumab
Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinoma
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and over
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer
Pembrolizumab with axitinib for untreated advanced renal cell carcinoma
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer
Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer
Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal)
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer
Pembrolizumab with pemetrexed and platinum-based chemotherapy for untreated unresectable advanced malignant pleural mesothelioma (terminated appraisal)
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer
Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma
Pemetrexed for the first-line treatment of non-small-cell lung cancer
Pemetrexed for the maintenance treatment of non-small-cell lung cancer
Pemetrexed for the treatment of malignant pleural mesothelioma
Pemetrexed for the treatment of non-small-cell lung cancer
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement
Pentosan polysulfate sodium for treating bladder pain syndrome
People's experience in adult social care services: improving the experience of care and support for people using adult social care services
People's experience using adult social care services
Peptest for diagnosing gastro‑oesophageal reflux
Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation
Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia
Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices
Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation
Percutaneous balloon valvuloplasty for fetal critical aortic stenosis
Percutaneous cementoplasty for palliative treatment of bony malignancies
Percutaneous closure of patent foramen ovale for recurrent migraine
Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events
Percutaneous coblation of the intervertebral disc for low back pain and sciatica
Percutaneous cryotherapy for renal cancer
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia
Percutaneous electrical nerve stimulation for refractory neuropathic pain
Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica
Percutaneous endoscopic colostomy
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation
Percutaneous endoscopic laser cervical discectomy
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access
Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum
Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer
Padeliporfin for untreated localised prostate cancer
Paige Prostate for prostate cancer
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy
Palliative care for adults: strong opioids for pain relief
Palliative photodynamic therapy for advanced oesophageal cancer
Pancreatic cancer
Pancreatic cancer in adults: diagnosis and management
Pancreatitis
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)
Panobinostat for treating multiple myeloma after at least 2 previous treatments
Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers
Parkinson's disease
Parkinson's disease in adults
Partial replacement of the meniscus of the knee using a biodegradable scaffold
Path Finder for freezing of gait in people with Parkinson's disease
Patient experience in adult NHS services
Patient experience in adult NHS services: improving the experience of care for people using adult NHS services
Patient group directions
Patient Status Engine for wireless monitoring of vital signs
Patiromer for treating hyperkalaemia
Patisiran for treating hereditary transthyretin amyloidosis
Pazopanib for the first-line treatment of advanced renal cell carcinoma
pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms
Pegaspargase for treating acute lymphoblastic leukaemia
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis
Pegunigalsidase alfa for treating Fabry disease
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine
Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (terminated appraisal)
Pegzilarginase for treating arginase-1 deficiency in people 2 years and over
Pelvic floor dysfunction: prevention and non-surgical management
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
Pembrolizumab for adjuvant treatment of renal cell carcinoma
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer
Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma
Pembrolizumab for advanced melanoma not previously treated with ipilimumab
Pembrolizumab for neoadjuvant and adjuvant treatment of resectable locally advanced head and neck squamous cell carcinoma
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer
Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and over
Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer
Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal)
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer
Pembrolizumab with axitinib for untreated advanced renal cell carcinoma
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
Pembrolizumab with carboplatin and paclitaxel for untreated primary advanced or recurrent endometrial cancer
Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer
Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal)
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer
Pembrolizumab with pemetrexed and platinum-based chemotherapy for untreated unresectable advanced malignant pleural mesothelioma (terminated appraisal)
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma
Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer
Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma
Pemetrexed for the first-line treatment of non-small-cell lung cancer
Pemetrexed for the maintenance treatment of non-small-cell lung cancer
Pemetrexed for the treatment of malignant pleural mesothelioma
Pemetrexed for the treatment of non-small-cell lung cancer
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement
Pentosan polysulfate sodium for treating bladder pain syndrome
People's experience in adult social care services: improving the experience of care and support for people using adult social care services
People's experience using adult social care services
Peptest for diagnosing gastro‑oesophageal reflux
Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation
Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia
Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices
Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation
Percutaneous balloon valvuloplasty for fetal critical aortic stenosis
Percutaneous cementoplasty for palliative treatment of bony malignancies
Percutaneous closure of patent foramen ovale for recurrent migraine
Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events
Percutaneous coblation of the intervertebral disc for low back pain and sciatica
Percutaneous cryotherapy for renal cancer
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia
Percutaneous electrical nerve stimulation for refractory neuropathic pain
Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica
Percutaneous endoscopic colostomy
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation
Percutaneous endoscopic laser cervical discectomy
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access
Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum
Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure